Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen – Sofia ref.: 115854

Project Information

EBOVAC1

Grant agreement ID: 115854

DOI 10.3030/115854

Project closed

EC signature date 5 March 2015

Start date 1 December 2014

End date 30 November 2021

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 98 044 688,00

EU contribution € 58 336 885,00

Coordinated by

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
United Kingdom